Mohan Bala, Ph.D.

Mohan Bala has spent over 20 years in the biopharmaceutical industry, with experience in both clinical development and commercialization. Most recently he was the overall program leader for the immuno-oncology portfolio at TESARO, Inc. Prior to that he held roles of increasing responsibility at Centocor, Johnson & Johnson, GlaxoSmithKline, and Sanofi. In these roles he contributed to the development and commercialization of multiple immunology and oncology products. Mohan holds a Ph.D. and M.B.A from the University of Chicago.